2. It is a medical imaging technique used to visualize the
inside of blood vessels and organs of the body, with
particular interest in the arteries, veins and the heart
chambers.
traditionally done by injecting a radio-opaque contrast
agent into the blood vessel and imaging using X-ray
based techniques
The word itself comes from the Greek words angeion,
"vessel", and graphein, "to write or record".
The film or image of the blood vessels is called an
angiograph, or more commonly, an angiogram.
3. - Fundus Fluorescein angiography refers
to photographing fluroscein dye in the
retinal vasculature following intravenous
injection of fluroscein sodium.
- Described in 1959 by MacLean and
Maumenee
4. Fluorescein (C20H12O5)
refers to Fluorescein
sodium (C20H10Na2).
Is a brown or orange-red
crystalline substance first
synthesized in 1871 in
Germany by Von Baeyer
5. 1882 – Ehrlich introduced Fluorescein into
investigative ophthalmology
1940 – Gifford studied aqueous dynamics after
injecting intravenous Fluorescein
1960 – 2 medical students Novotny & Alwis
experimented on each other and developed
FFA
6. Non toxic, inexpensive, safe
Alkaline solution
Highly fluorescent
Absorbs blue light (480-500 nm)
Emits yellow-green (500-600 nm [525
nm])
Effective at pH 7.37-7.45
Removal from blood by kidneys and liver
within 5 hrs.
7. Inner and Outer blood retinal barriers
control movement of fluid, ions &
electrolytes from intravascular space to
extracellular space in retina
FFA – method of examining competence
of blood retinal barriers and making
permanent record
9. 70-85% fluorescein molecules bind to
serum proteins (mainly albumin) on
entering the circulation.
The rest unbound molecules are referred
to as free fluorescein.
10. At level of retinal capillary endothelium (tight
junctions, non-fenestrated) and basement
membrane
Prevents all leaks of free fluorescein and
albumin-bound fluorescein.
in vascular permeability caused by changes in
intravascular pressure or tissue hydrostatic
pressure, or by change in capillary walls
themselves, will permit leakage of both bound &
free fluorescein molecules in extra vascular
space.
11. -impermeable to both bound & free
fluorescein molecules.
- walls of choricapillaries are extremely
thin & contain multiple fenestrations
through which free fluorescein molecules
are able to escape into the extra vascular
space & across Bruch’s membrane.
12. Composed of intact RPE (tight junctions
b/w RPE cells).
Impermeable to free fluorescein.
RPE presents an optical barrier to
fluorescein and masks choroidal
circulation
13. 490 nm (blue part of spectrum).
represents maximal absorption of light
energy by fluorescein.
Molecules stimulated by this wavelength
will be excited to higher energy level &
will emit light of longer wavelength
( green portion of spectrum i.e. at 530 nm
).
14. 2 types of filters:-
- cobalt-blue excitation.
- yellow-green barrier.
Ensures blue light enters the eye & only
yellow green light enters the camera.
15. Light emitted from retinal camera passes
through blue excitation filter, emerging
blue light enters the eye & excites
Fluorescein molecules in retinal & choroid
circulation of longer wavelength (yellow
green).
Yellow green barrier filter thus blocks any
blue light that may leave eye, allowing only
yellow-green light to pass through
unimpaired to be recorded on film.
16. - Pupil should be dilated.
TECHNIQUE:-
- Patient seated in front of camera with one arm
out stretched.
- Fluorescein 5 ml of 10% solution is drawn up
into syringe.
In opaque media, 3 ml of 25% solution may be
preferred, because it gives better result.
17. - Red free photograph is taken.
- Fluorescein injected rapidly into antecubital
vein.
- Photographs are taken at approx 1 sec interval
between 5 & 25 sec after injection.
- After transit phase has been photographed in
eye, control pictures are taken of opposite eye.
If necessary, late photograph can also be
taken after 10 min & occasionally after 20 min if
leakage is anticipated.
18. Red after image.
Transient nausea.
Flushing of skin.
Itching.
Hives.
Excessive sneezing.
Discolouration of urine & skin.
19. Baseline photos and red free
5 Phases of FFA
Choroidal phase
Arterial phase
Capillary phase
Venous phase
Late phase
20. 1) CHOROIDAL OR PRE-ARTERIAL PHASE:-
-Choroidal circulation is filling, but no dye has
reached the retinal arteries.
2) ARTERIAL PHASE:-
-follows 1 sec after pre-arterial phase.
-extends from first appearance of dye in the
arteries until whole arterial circulation is filled.
3)CAPILLARY OR ARTERIOVENOUS PHASE:-
-characterized by complete filling of the arteries
& capillaries with early lamellar flow in the
veins.
21. 4) VENOUS PHASE:-
- subdivided into early, mid & late stages according to
extent of venous filling & arterial emptying.
early venous phase:- shows complete arterial & capillary
filling, & lamellar venous flow.
mid venous phase:- shows almost complete venous filling.
late venous phase:- shows complete venous filling.
-arteries are beginning to show decreasing
fluorescence.
-Recirculation of dye occurs within 3-5 min.
-The intensity of fluorescence begins to diminish so
that arteries & veins appear equally fluorescent.
22. 5) LATE PHASES:-
- shows effects of continuous recirculation,
dilution & elimination of dye.
- with each succeeding wave, the intensity
of fluorescence becomes weaker.
- late staining of optic nerve is a normal
finding.
23. Arm to retina (ONH) 7-12s
Posterior- ciliary artery fill 9s
Choroidal flush, cilio-retinal artery 10s
Retinal arterial phase 10-12s
Capillary transition phase 13s
Early venous/lamellar/a-v phase 14-15s
Venous phase 16-17s
Late venous phase 18-20s
Late phase 5 – 15 mins
25. Arterial phase may range from 2-30s;
may be affected by:
- cardiac disease
- blood viscosity
- vessel calibre
- CCF
- GCA
- BP↑
- carotid artery stenosis.
26. Superior arterioles fill before inferior and
temporal before nasal
Choroidal & scleral fluorescence depends on
pigment density of RPE & its integrity
Macular hypo fluorescence – due to ’d density↑
of RPE & xanthophyll blocking choroidal
fluorescence
No retinal capillaries – FAZ 500μm; foveola
350μm
27. Only 2 fundamental principles in FFA
- HYPER fluorescence or
HYPO fluorescence !
28. MAY BE CAUSED BY:-
1) AN RPE WINDOW DEFECT:
-RESULTING FROM ATROPHY OF
OVERLYING RPE CELLS WITH
UNMASKING OF NORMAL
BACKGROUND CHOROIDAL
FLUORESCENCE.
29. 2) POOLING OF DYE:-
-UNDER A DETACHMENT OF RPE OR IN
IN THE SUB RETINAL SPACE.
- CAUSED BY A BREAKDOWN OF
OUTER BLOOD RETINAL BARRIER.
30. 3) LEAKAGE OF DYE:-
- into the sensory retina as a result of
breakdown of inner blood retinal barrier.
- may be:-
~from choroidal new vessels.
~from retinal new vessels.
~from the optic nerve head
(in papilloedema).
31. 4) STAINING OF TISSUES:-
- as a result of prolonged retention of
fluorescence.
32. Permeability defects cause pooling &
staining
Pooling – serous RPE detachment, SRF (↑
in size, shape & intensity in later phases)
Staining – sclera, ON, drusen, vasculitis.
(Leak into tissue rather than anatomical space)
33. May be caused by :-
1) BLOCKAGE OF FLUORESCENCE:-
- by increased density of pigment
(xanthophyll -sensory retina,
melanin- RPE)
- deposition of abnormal materials
( hard exudates in sensory retina,
lipofuscin in Best’s disease)
- Blood.
34. 2)obstruction of retinal and choroidal
circulation:-
- preventing access of fluorescein to the
tissues.
3) loss of vascular tissues:-
- in severe myopic degeneration or
choroideremia.
35. Due to the 2 barrier filters not having
mutually exclusive transmission spectra
Light from bright fundal structures can
pass through both filters & expose film.
e.g. ONH drusen, astrocytic hamartomas
36. Autofluorescence can
be diagnostic
FFA can exclude
papilloedema
Saves pt from
invasive neuro
diagnostic
procedures!
Optic nerve head drusen
37. CB readily leaks fluorescein during
aqueous production, into ocular fluids.
Green light emitted when excited by
blue light. Illuminates light coloured
structures eg: MNF’s, white lesions
38. To aid diagnosis
Decisions on whether to Rx or not
Always study FFA’s with other relevant
investigations before making final
diagnosis
39. Start by describing obvious abnormality
Describe hypo/hyperfluorescent
components
Intensity of fluorescence with time
Area of fluorescence & changes with time
40. Run through anatomical list describing
any other abnormalities affecting
structures below:
Macula
Disc
Major arcades
Capillaries
41. Early venous phase
HyperF – NVD, ma’s
HypoF – blocked due
to blood
48. Non-perfusion of retinal
vasculature.Vessels appear
dark against light background
No capillary perfusion, so
empty veins (cattle-trucking)
Choroidal perfusion intact
(hence “cherry red spot”); C-
R artery sparing in 15%
49. RPE atrophy allows
choroidal fluorescence
through with choroidal
“flush”
Does not change size or
shape with time
Fades with choroidal
fluorescence
Red Free
Late
50. Large area of GA
Clear view of
choroidal vessels
FFA shows
unmasking of
choroidal vessels
52. Small defect in outer
BR barrier
F enters RPE defect &
fills serous retinal
elevation “blister” (7%
cases)
HyperF - ’s in size &↑
intensity
Early
Late
53. Breakdown of internal BR
barrier
Early leak from
parafoveal retinal vessels
– hyperF, in FAZ↓
Late pooling in classic
“petalloid” appearance
(NFL)
54. Ischaemia & vasculitis
incompetent endothelial
TJ’s
F leaks into CT of bv’s &
stains it.This persists
Late disc staining is
normal
ARN
Pars planitis
55. Early lacey hyperF
“classic”
HypoF “halo” – blood
&/or macula pigment
Late leak, blurred
margins & apparent ↑
in size
56. Type I – PED – well-
defined area of early
hyperF, margins
unchanged
Type II – late leak of
undeyermined
source – not obvious
from early phase